Compare with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GENERIC PHARMASEC vs ISHAN DYES & CHEMICALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GENERIC PHARMASEC ISHAN DYES & CHEMICALS GENERIC PHARMASEC/
ISHAN DYES & CHEMICALS
 
P/E (TTM) x 86.8 10.9 792.5% View Chart
P/BV x 8.7 2.4 358.7% View Chart
Dividend Yield % 0.0 2.3 -  

Financials

 GENERIC PHARMASEC   ISHAN DYES & CHEMICALS
EQUITY SHARE DATA
    GENERIC PHARMASEC
Mar-21
ISHAN DYES & CHEMICALS
Mar-21
GENERIC PHARMASEC/
ISHAN DYES & CHEMICALS
5-Yr Chart
Click to enlarge
High Rs1759 28.4%   
Low Rs718 40.6%   
Sales per share (Unadj.) Rs0.851.2 1.5%  
Earnings per share (Unadj.) Rs08.0 0.6%  
Cash flow per share (Unadj.) Rs09.3 0.5%  
Dividends per share (Unadj.) Rs02.25 0.0%  
Avg Dividend yield %05.9 0.0%  
Book value per share (Unadj.) Rs0.740.9 1.8%  
Shares outstanding (eoy) m276.8615.97 1,733.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x15.60.7 2,081.6%   
Avg P/E ratio x263.54.8 5,526.4%  
P/CF ratio (eoy) x260.94.1 6,333.8%  
Price / Book Value ratio x16.00.9 1,714.4%  
Dividend payout %028.1 0.0%   
Avg Mkt Cap Rs m3,314611 542.6%   
No. of employees `000NANA-   
Total wages/salary Rs m261 3.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m213817 26.1%  
Other income Rs m322 14.7%   
Total revenues Rs m216840 25.8%   
Gross profit Rs m12177 6.7%  
Depreciation Rs m020 0.6%   
Interest Rs m07 0.0%   
Profit before tax Rs m15172 8.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m344 5.7%   
Profit after tax Rs m13128 9.8%  
Gross profit margin %5.621.7 25.8%  
Effective tax rate %16.725.6 65.1%   
Net profit margin %5.915.7 37.7%  
BALANCE SHEET DATA
Current assets Rs m268557 48.0%   
Current liabilities Rs m72221 32.4%   
Net working cap to sales %92.141.1 223.9%  
Current ratio x3.72.5 148.5%  
Inventory Days Days14828 531.4%  
Debtors Days Days128,898,635118,746,869 108.5%  
Net fixed assets Rs m10378 2.7%   
Share capital Rs m277160 173.4%   
"Free" reserves Rs m-70493 -14.2%   
Net worth Rs m207653 31.6%   
Long term debt Rs m07 0.0%   
Total assets Rs m278935 29.7%  
Interest coverage xNM24.8-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.9 87.6%   
Return on assets %4.514.5 31.2%  
Return on equity %6.119.6 31.0%  
Return on capital %7.327.2 26.8%  
Exports to sales %059.0 0.0%   
Imports to sales %010.8 0.0%   
Exports (fob) Rs mNA482 0.0%   
Imports (cif) Rs mNA88 0.0%   
Fx inflow Rs m0482 0.0%   
Fx outflow Rs m093 0.0%   
Net fx Rs m0390 0.0%   
CASH FLOW
From Operations Rs m-21-23 91.9%  
From Investments Rs m-14-33 43.3%  
From Financial Activity Rs m4548 93.4%  
Net Cashflow Rs m10-8 -124.5%  

Share Holding

Indian Promoters % 0.0 58.5 -  
Foreign collaborators % 60.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 40.0 41.5 96.5%  
Shareholders   17,121 5,797 295.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GENERIC PHARMASEC With:   BODAL CHEMICALS  BHAGERIA INDUSTRIES  VIDHI SPECIALTY FOOD INGREDIENTS  DYNEMIC PRODUCTS  BAGADIA COLOURCHEM  



Today's Market

5 Reasons Why Sensex Plunged 765 Points Today(Closing)

It was a volatile day for Indian share market today. After opening the day in green, benchmark indices erased gains within the first hour and kept falling as the session progressed.

Related Views on News

Ami Organics Stock Makes Impressive Debut on Bourses. Lists at 49% Premium (Views On News)

Sep 14, 2021

Shares of Ami Organics makes a strong debut on the stock exchange. Did you bid for the IPO?

Chemplast Sanmar Makes Flat Debut as IPO Frenzy Fizzles Out (Views On News)

Aug 24, 2021

The grey market had indicated a flat listing for shares of Chemplast Sanmar ahead of its debut.

Understanding Aarti Industries' Demerger (Views On News)

Aug 20, 2021

Will the pharma unit's demerger unlock value for shareholders?

What Next for Devyani, Zomato, & Tatva Chintan Pharma After Stellar IPO Gains? (Views On News)

Aug 20, 2021

What's the outlook for Devyani, Zomato, and Tatva Chintan Pharma after robust listings?

Pidilite Results Review: Net Profit Spikes as Sales Rise 121% (Views On News)

Aug 12, 2021

Pidilite posts strong sales growth and a multi-fold jump in bottomline.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GENERIC PHARMASEC SHARE PRICE


Dec 3, 2021 (Close)

TRACK GENERIC PHARMASEC

  • Track your investment in GENERIC PHARMASEC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GENERIC PHARMASEC

GENERIC PHARMASEC 8-QTR ANALYSIS

COMPARE GENERIC PHARMASEC WITH

MARKET STATS